S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 124 900 KRW Market Closed
Market Cap: 2.6T KRW

Wall Street
Price Targets

Price Targets Summary
ST Pharm Co Ltd

Wall Street analysts forecast ST Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 133 705 KRW with a low forecast of 101 000 KRW and a high forecast of 168 000 KRW.

Lowest
Price Target
101 000 KRW
19% Downside
Average
Price Target
133 705 KRW
7% Upside
Highest
Price Target
168 000 KRW
35% Upside
ST Pharm Co Ltd Competitors:
Price Targets
1548
Genscript Biotech Corp
89% Upside
TKNO
Alpha Teknova Inc
124% Upside
603259
WuXi AppTec Co Ltd
43% Upside
CGEN
Compugen Ltd
319% Upside
207940
Samsung Biologics Co Ltd
133% Upside
INNOVACAP
Innova Captab Ltd
15% Upside
300759
Pharmaron Beijing Co Ltd
31% Upside
SAILIFE
Sai Life Sciences Ltd
22% Upside

Revenue
Forecast

Revenue Estimate
ST Pharm Co Ltd

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 22%.

11%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ST Pharm Co Ltd

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 52%.

11%
Past Growth
52%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
ST Pharm Co Ltd

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 34%.

20%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ST Pharm Co Ltd's stock price target?
Price Target
133 705 KRW

According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 133 705 KRW with a low forecast of 101 000 KRW and a high forecast of 168 000 KRW.

What is ST Pharm Co Ltd's Revenue forecast?
Projected CAGR
22%

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 22%.

What is ST Pharm Co Ltd's Operating Income forecast?
Projected CAGR
52%

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 52%.

What is ST Pharm Co Ltd's Net Income forecast?
Projected CAGR
34%

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 34%.

Back to Top